Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be? (2021)
- Authors:
- Wendel, Silvano
- Fachini, Roberta
- Wendel, Rita C. L. Fontão
- Santos, Ralyria Mello Vieira dos
- Velasquez, Carlos Vinícius
- Machado, Rafael Rahal Guaragna
- Brito, Mayra Altobelli
- Amaral, Marcelo
- Soares, Camila Pereira
- Achkar, Ruth
- Scuracchio, Patrícia
- Miyaji, Sandra Cristina
- Erdens, Melina Santos
- Durigon, Edison Luiz
- Wendel, Silvano
- USP affiliated authors: DURIGON, EDISON LUIZ - ICB ; MACHADO, RAFAEL RAHAL GUARAGNA - ICB ; SOARES, CAMILA PEREIRA - ICB
- Unidade: ICB
- DOI: 10.1111/trf.16714
- Subjects: MICROBIOLOGIA; ANTIVIRAIS; COVID-19; DOADORES DE SANGUE; TESTES SOROLÓGICOS; PLASMA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Transfusion
- ISSN: 1537-2995
- Volume/Número/Paginação/Ano: v. 61, n. 12, p. 3455-3467, 2021
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: hybrid
- Licença: cc-by-nc
-
ABNT
WENDEL, Silvano et al. Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be?. Transfusion, v. 61, n. 12, p. 3455-3467, 2021Tradução . . Disponível em: https://doi.org/10.1111/trf.16714. Acesso em: 11 nov. 2024. -
APA
Wendel, S., Fachini, R., Wendel, R. C. L. F., Santos, R. M. V. dos, Velasquez, C. V., Machado, R. R. G., et al. (2021). Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be? Transfusion, 61( 12), 3455-3467. doi:10.1111/trf.16714 -
NLM
Wendel S, Fachini R, Wendel RCLF, Santos RMV dos, Velasquez CV, Machado RRG, Brito MA, Amaral M, Soares CP, Achkar R, Scuracchio P, Miyaji SC, Erdens MS, Durigon EL. Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be? [Internet]. Transfusion. 2021 ; 61( 12): 3455-3467.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1111/trf.16714 -
Vancouver
Wendel S, Fachini R, Wendel RCLF, Santos RMV dos, Velasquez CV, Machado RRG, Brito MA, Amaral M, Soares CP, Achkar R, Scuracchio P, Miyaji SC, Erdens MS, Durigon EL. Surrogate test performance for SARS-CoV-2 neutralizing antibodies (nAbs) for convalescent plasma (CCP): how useful could they be? [Internet]. Transfusion. 2021 ; 61( 12): 3455-3467.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1111/trf.16714 - A longitudinal study of convalescent plasma (CCP) donors and correlation of ABO group, initial neutralizing antibodies (nAb), and body mass index (BMI) with nAb and anti‐nucleocapsid (NP) SARS‐CoV‐2 antibody kinetics: proposals for better quality of CCP collections
- Anti‐A and SARS‐CoV‐2: an intriguing association
- Development and validation of an enzyme-linked immunoassay kit for diagnosis and surveillance of COVID-19
- Cross-lineage protection between chikv primary infection and mayv secondary exposure in mice
- Convalescent plasma for COVID-19 in hospitalised patients: an open-label, randomised clinical trial
- Screening for SARS‐CoV‐2 antibodies in convalescent plasma in Brazil: preliminary lessons from a voluntary convalescent donor program
- SARS-CoV-2 rapid antigen test based on a new anti-nucleocapsid protein monoclonal antibody: development and real-time validation
- Heterogeneous development of children with congenital Zika Syndrome-associated microcephaly
- Nebulized enriched heparin improves respiratory parameters in patients with COVID-19: a phase I/II randomized and triple-blind clinical trial
- Nebulized enriched heparin to treat no critical patients with Sars-Cov-2: triple-blind clinical trial
Informações sobre o DOI: 10.1111/trf.16714 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
Surrogate test performanc... | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
